Routine medical care (active comparator)

DRUG2 trials

Sponsors

The University of Hong Kong

Conditions

Diabetic Kidney DiseaseDiabetic Nephropathies

Phase 2

Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy

The University of Hong KongDiabetic Nephropathies

Start: 2015-07-31End: 2021-09-30Target: 148Updated: 2021-04-30

Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

The University of Hong KongDiabetic Kidney Disease, Diabetic Nephropathies

Start: 2018-07-01End: 2022-12-31Target: 118Updated: 2020-12-07

Related Papers

Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.

2024-02-2817 citations

Add-on Rehmannia-6–Based Chinese Medicine in Type 2 Diabetes and CKD

Clinical Journal of the American Society of Nephrology2023-06-1210 citations

Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial

BMJ Open2021-01-0112 citations

Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial

BMJ Open2016-08-019 citations